1.21
Lifeward Ltd stock is traded at $1.21, with a volume of 95,360.
It is up +1.68% in the last 24 hours and down -9.70% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
See More
Previous Close:
$1.19
Open:
$1.2
24h Volume:
95,360
Relative Volume:
0.05
Market Cap:
$13.54M
Revenue:
$23.28M
Net Income/Loss:
$-23.75M
P/E Ratio:
-0.3967
EPS:
-3.05
Net Cash Flow:
$-25.22M
1W Performance:
-1.63%
1M Performance:
-9.70%
6M Performance:
-32.78%
1Y Performance:
-73.64%
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LFWD
Lifeward Ltd
|
1.21 | 13.54M | 23.28M | -23.75M | -25.22M | -3.05 |
![]()
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-10-25 | Initiated | Laidlaw | Buy |
Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
Dec-16-16 | Initiated | Oppenheimer | Outperform |
Jul-15-16 | Initiated | Piper Jaffray | Overweight |
May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
May-08-15 | Reiterated | Barclays | Equal Weight |
Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward’s CFO to resign - Worcester Business Journal
Lifeward CFO Michael Lawless to Step Down - marketscreener.com
lifeward ltd. cfo michael lawless announces resignation By Investing.com - Investing.com South Africa
lifeward ltd. cfo michael lawless announces resignation - Investing.com
Lifeward stock initiated with buy rating at Litchfield Hills Research - Investing.com Australia
Lifeward stock initiated with buy rating at Litchfield Hills Research By Investing.com - Investing.com India
LFWD stock touches 52-week low at $1.22 amid market challenges - Investing.com Australia
Lifeward Names Mark Grant as New CEO - GlobeNewswire
Lifeward to Present at Sidoti Virtual Investor Conference on May 21 - GlobeNewswire
Lifeward names Mark Grant as new CEO By Investing.com - Investing.com South Africa
Lifeward Appoints Mark Grant As New CEO: Retail Sentiment Dips By Stocktwits - Investing.com India
Lifeward Names Mark Grant as New CEO | LFWD Stock News - GuruFocus
Lifeward names Mark Grant as new CEO - Investing.com Australia
Lifeward (LFWD) Appoints Mark Grant as New CEO | LFWD Stock News - GuruFocus
Lifeward Announces New CEO Appointment Effective June 2025 - TipRanks
Lifeward appoints Grant as new President, CEO - TipRanks
Medical Tech Leader Lifeward Names 30-Year Industry Veteran Mark Grant as CEO to Accelerate ReWalk Innovation - Stock Titan
Lifeward, Ltd. to Present at Sidoti May Virtual Investor Conference 2025 - Nasdaq
Medical Tech Leader Lifeward Brings Innovation Story to Sidoti Conference: Free Registration Open - Stock Titan
Lifeward reaffirms $28M–$30M 2025 revenue guidance as pipeline expands 70% and cost controls tighten - MSN
Lifeward files $100M mixed securities shelf - MSN
Lifeward: Q1 Earnings Snapshot - CT Insider
Lifeward Ltd (LFWD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Lifeward Inc. Earnings Call: Optimism Amid Challenges - TipRanks
LFWD Misses Q1 Revenue Estimates, Expects Improvement in Medicare Claims Process | LFWD Stock News - GuruFocus
Lifeward earnings missed by $0.18, revenue fell short of estimates - Investing.com Australia
Lifeward (LFWD) Announces $100 Million Mixed Securities Shelf Of - GuruFocus
Lifeward (LFWD) Announces $100 Million Mixed Securities Shelf Offering | LFWD Stock News - GuruFocus
Lifeward Ltd Q1 2025 Earnings: EPS Misses at -$0.46, Revenue Fal - GuruFocus
Transcript : Lifeward Ltd., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Lifeward Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Lifeward Ltd. Provides Revenue Guidance for the Year 2025 - marketscreener.com
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Lifeward Ltd. SEC 10-Q Report - TradingView
Form 10-Q Lifeward Ltd. For: Mar 31 - StreetInsider
Lifeward (LFWD) Maintains Revenue Outlook for 2025 | LFWD Stock News - GuruFocus
ReWalk Robotics Q1 2025 Earnings Report - MarketBeat
Lifeward Ltd. Reports First Quarter 2025 Financial Results | LFW - GuruFocus
Lifeward Ltd. Reports First Quarter 2025 Financial Results - The Manila Times
Lifeward (LFWD) Advances Exoskeleton Technology with AI Integration | LFWD Stock News - GuruFocus
Lifeward Completes Research Program with Israeli - GlobeNewswire
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons - marketscreener.com
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 - The Manila Times
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifeward Ltd Stock (LFWD) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Lind Global Fund II LP | 10% Owner |
Jan 06 '25 |
Sale |
3.36 |
381,676 |
1,283,102 |
1,049,430 |
Lind Global Fund II LP | 10% Owner |
Jan 07 '25 |
Sale |
1.94 |
191,434 |
371,907 |
857,996 |
Richner Randel | Director |
Dec 13 '24 |
Sale |
1.68 |
4,285 |
7,214 |
0 |
Turk Joseph E Jr | Director |
Dec 13 '24 |
Buy |
1.69 |
6,000 |
10,140 |
18,516 |
Swinford Michael | Director |
Nov 25 '24 |
Buy |
2.03 |
21,622 |
43,858 |
65,040 |
Swinford Michael | Director |
Nov 22 '24 |
Buy |
1.83 |
16,907 |
30,899 |
43,418 |
Swinford Michael | Director |
Nov 20 '24 |
Buy |
1.84 |
16,471 |
30,231 |
26,511 |
Jasinski Lawrence J | Chief Executive Officer |
Sep 13 '24 |
Sale |
3.26 |
2,672 |
8,700 |
100,637 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):